Si Nguyen Van, Fujioka Daisuke, Watanabe Kazuhiro, Watanabe Yosuke, Watanabe Kazunori, Nakamura Kazuto, Yamaguchi Kazuyuki, Uematsu Manabu, Kugiyama Kiyotaka
Department of Internal Medicine Ⅱ, University of Yamanashi, Faculty of Medicine.
J Atheroscler Thromb. 2016 Oct 1;23(10):1227-1241. doi: 10.5551/jat.34330. Epub 2016 Mar 29.
Phospholipase A receptor 1 (PLAR) has multiple biological functions other than functioning as a receptor for secretory PLAs. Two nonsynonymous polymorphisms in the C-type lectin-like domains (CTLD) 1 of PLAR gene have been associated with idiopathic membranous nephropathy. This study examined whether the same PLAR polymorphisms may alter functions of PLAR in cells expressing the variant PLAR. In addition, the clinical relevance of the experiment was examined.
Two nonsynonymous polymorphisms (T/C at rs3749117 and G/C at rs35771982) in CTLD1 of PLAR gene were completely linked. HEK293 cells expressing human wild-type PLAR (T at rs3749117 and G at rs35771982) or human mutant PLAR that had double mutations (C at rs3749117 and C at rs35771982) were constructed.
HEK293 cells expressing mutant PLAR had lower migratory and proliferative responses to collagen I compared with cells expressing wild-type PLAR. In 580 male patients, PLAR gene polymorphisms were associated with an increase in maximum intima-media thickness (maxIMT) of the carotid artery. The multivariate regression model showed that PLAR gene polymorphisms were a risk factor of an increased maxIMT that was independent of conventional risk factors (OR=1.93, 95% CI: 1.17-3.19, p<0.01).
The nonsynonymous common variants of PLAR gene altered biological functions in cells expressing variant PLAR. PLAR gene polymorphisms present a genetic risk of an increased IMT of the carotid artery in male. The functional changes in the variant PLAR may potentially be responsible for its association with an increased IMT of the carotid artery.
磷脂酶A受体1(PLAR)除作为分泌型磷脂酶A的受体发挥作用外,还具有多种生物学功能。PLAR基因C型凝集素样结构域(CTLD)1中的两个非同义多态性与特发性膜性肾病相关。本研究检测了相同的PLAR多态性是否会改变表达变异型PLAR的细胞中PLAR的功能。此外,还检测了该实验的临床相关性。
PLAR基因CTLD1中的两个非同义多态性(rs3749117处的T/C和rs35771982处的G/C)完全连锁。构建了表达人野生型PLAR(rs3749117处为T,rs35771982处为G)或具有双突变(rs3749117处为C,rs35771982处为C)的人突变型PLAR的HEK293细胞。
与表达野生型PLAR的细胞相比,表达突变型PLAR的HEK293细胞对I型胶原的迁移和增殖反应较低。在580名男性患者中,PLAR基因多态性与颈动脉最大内膜中层厚度(maxIMT)增加相关。多变量回归模型显示,PLAR基因多态性是maxIMT增加的危险因素,独立于传统危险因素(OR=1.93,95%CI:1.17-3.19,p<0.01)。
PLAR基因的非同义常见变异改变了表达变异型PLAR的细胞中的生物学功能。PLAR基因多态性在男性中存在颈动脉IMT增加的遗传风险。变异型PLAR的功能变化可能潜在地导致其与颈动脉IMT增加的关联。